CONMED Corp — Director's Dealing 2013

Sep 16, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-09-12

Reporting Person: CORASANTI JOSEPH J (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-12	Common Stock	M	19352	$31.40	Acquired	133500	Direct
2013-09-12	Common Stock	S	19352	$33.0901	Disposed	114148	Direct
2013-09-13	Common Stock	M	25500	$31.40	Acquired	139648	Direct
2013-09-13	Common Stock	S	25500	$33.0029	Disposed	114148	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-12	Options To Purchase Common Stock	$31.40	M	19352	Disposed	2015-05-17	Common Stock (19352)	Direct
2013-09-13	Options To Purchase Common Stock	$31.40	M	25500	Disposed	2015-05-17	Common Stock (25500)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.23. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.07. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.